zofran lawsuit

  • Date: Jul 01, 2015
  • Category: Legal

ZofranLegal.com Reports A New Zofran Lawsuit: Massachussetts Mother Alleges Drug Caused Heart Defects

On February 16, 2015, a Boston mother filed the first birth defect lawsuit against GlaxoSmithKline, initiating a litigation that has since grown to at least ten individual claims. Families accuse the pharmaceutical giant of concealing evidence that its anti-nausea drug Zofran increases the risk of major birth defects, while unlawfully promoting the drug for use during pregnancy. Continue reading →

  • Date: Jun 12, 2015
  • Category: Family

In Louisiana, Two New Plaintiffs Claim Zofran Caused Critical Heart Defects

On June 8, 2015, two mothers from Louisiana filed their own complaint in a litigation that has now grown to at least 10 individual personal injury lawsuits. Families from across the country are bringing claims against GlaxoSmithKline, alleging that the company’s anti-nausea drug causes major birth defects. Continue reading →

  • Date: Jun 01, 2015
  • Category: Family

Minnesota Mother Claims Zofran Caused Congenital Heart Defect In Two Pregnancies

On February 12, 2015, a parent from Alexandria, Minnesota filed the first claim in a litigation that has since grown to at least seven lawsuits. Families have brought claims for compensation against GlaxoSmithKline, the manufacturer of Zofran, an anti-nausea drug that these parents say causes major birth defects. Continue reading →

  • Date: May 08, 2015
  • Category: Family

A New Zofran Lawsuit Claims Birth Defects Caused Termination

On April 17, 2015, a woman from Massachusetts filed suit against pharmaceutical giant GlaxoSmithKline. She claims that Zofran, an anti-nausea drug frequently prescribed “off-label” to treat morning sickness, caused her unborn child to develop a severe abdominal birth defect. As a result, plaintiff was forced to terminate her pregnancy. Continue reading →

  • Date: Apr 28, 2015
  • Category: Family

Plaintiff In Texas Claims Zofran Caused “Numerous Birth Defects”

On April 17, 2015, a mother from Texarkana, Texas filed suit against GlaxoSmithKline, manufacturer of the anti-nausea drug Zofran. Plaintiff claims that Zofran, often prescribed “off-label” to treat morning sickness, caused her unborn child to develop multiple congenital defects. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 17, 2015
  • Category: Legal

Monheit Law Releases A 12 Point Guide To Zofran Birth Defect Lawsuits

In order to better inform the public, a national coalition of distinguished plaintiffs’ attorneys has released a comprehensive guide on litigation surrounding GlaxoSmithKline’s popular anti-nausea drug Zofran. Recent studies have begun to establish a link between Zofran’s active ingredient, Ondansetron, and severe birth defects including cleft palate and congenital heart defects. Now, recently-filed lawsuits (filed under case numbers 1:15-cv-10429 and 2:15-cv-00709PD) claim that GlaxoSmithKline was aware of Zofran’s risks, but unlawfully marketed the drug to obstetricians and gynecologists as a safe treatment for morning sickness. Continue reading →

National Alliance of Attorneys Filing Zofran Birth Defect Lawsuits

A national alliance of plaintiffs’ attorneys have begun filing Zofran birth defect lawsuits. Several independent studies have linked Zofran to a potential increased risk of child birth defects such as cleft palate, and congenital heart defects. Continue reading →